Founders Capital Management (Texas)’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,000
| Closed | -$5K | – | 328 |
|
|
2019
Q3 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 300 |
|
|
2019
Q2 | $6K | Hold |
1,000
| – | – | 0.01% | 294 |
|
|
2019
Q1 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 306 |
|
|
2018
Q4 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 306 |
|
|
2018
Q3 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 276 |
|
|
2018
Q2 | $8K | Hold |
1,000
| – | – | 0.01% | 265 |
|
|
2018
Q1 | $7K | Hold |
1,000
| – | – | 0.01% | 309 |
|
|
2017
Q4 | $6K | Buy |
+1,000
| New | +$6K | 0.01% | 310 |
|